Skip to main content
. 2012 Jul 2;33(17):2163–2171. doi: 10.1093/eurheartj/ehs167

Figure 4.

Figure 4

The treatment recommendation table including new agents. The treatment recommendation table with settings: treatment threshold = 0.5%, bleeding ratio = 2:1, cost threshold = null, and jurisdiction = null. The stroke risk increases from the left to the right along with the CHA2DS2-VASc scores at the bottom. The bleeding risk increases from the bottom to the top along with the HAS-BLED scores on the left. The black boxes represent impossible combinations of the stroke and bleed risk due to overlapping risk factors. Apixaban is recommended for a patient with a CHA2DS2-VASc score 2 and HAS-BLED score 2.